postmenopausal

Related by string. post menopausal * * obese postmenopausal . postmenopausal osteoporosis . Postmenopausal Osteoporosis . shunning postmenopausal hormone . postmenopausal women . postmenopausal hormone therapy . postmenopausal osteoporosis PMO . postmenopausal hormone replacement . Postmenopausal hormone therapy . Postmenopausal Hormone Therapy . Postmenopausal women *

Related by context. All words. (Click for frequent words.) 75 post menopausal 74 postmenopausal women 74 premenopausal 68 pre menopausal 66 premenopausal women 62 perimenopausal women 62 estrogen therapy 61 menopause 61 oophorectomy 61 irregular menstrual cycles 61 vertebral fracture 61 anovulatory infertility 61 menopausal 60 menopausal symptoms 60 hip BMD 60 undergone hysterectomy 60 premenopausal breast cancer 60 tibolone 60 invasive breast cancer 60 folate intake 60 menopausal hormone therapy 59 lipid lowering therapy 59 postmenopausal breast cancer 59 calcium supplementation 59 postmenopausal hormone therapy 59 nulliparous women 59 folate supplementation 58 subclinical hypothyroidism 58 endometrial hyperplasia 58 hormone therapy estrogen 58 MetS 58 menopausal women 58 knee osteoarthritis 58 cardiovascular mortality 58 mild gestational diabetes 58 androgen deficiency 58 hypogonadal men 58 estrogen receptor negative 58 spontaneous preterm delivery 58 hormone therapy 57 osteoporotic fracture 57 bilateral oophorectomy 57 bone mineral 57 osteoporotic 57 spontaneous preterm birth 57 dietary calcium intake 57 perimenopausal 57 estrogen progestin therapy 57 normotensive 57 testosterone supplementation 57 vasomotor symptoms 57 ovarian function 57 colorectal adenomas 57 menstrual bleeding 57 BRCA mutation 57 calcium intake 57 CARDIA 57 endometrial cancer 57 estrogen deficiency 57 tamoxifen therapy 57 nonpregnant women 57 ovulatory cycles 57 menopausal symptom 57 vitamin D supplementation 57 bone density 57 osteopenic 56 dysmenorrhea 56 hip fracture 56 teriparatide 56 polycystic ovary syndrome PCOS 56 magnesium intake 56 hypogonadal 56 CC genotype 56 vaginal atrophy 56 osteopenia 56 abnormal Pap test 56 raloxifene 56 recurrent VTE 56 GnRH agonists 56 antihypertensive therapy 56 postmenopause 56 BRCA1 mutations 56 perimenopause 56 thyroid hormone levels 56 bisphosphonate therapy 56 hormonal therapy 55 osteoporosis 55 fragility fracture 55 polycystic ovarian syndrome PCOS 55 parous women 55 hot flashes 55 undergoing radical prostatectomy 55 DMPA 55 thyroid dysfunction 55 Dietary Modification Trial 55 postmenopausal hormones 55 breast cancer recurrence 55 Postmenopausal 55 bisphosphonate 55 nondiabetic 55 tamoxifen 55 T1DM 55 adiponectin levels 55 longitudinal cohort study 55 statin therapy 55 abnormal mammogram 55 obese postmenopausal 55 BRCA2 mutations 55 urinary symptoms 55 Sexual dysfunction 55 Wactawski Wende 55 prospective cohort 55 dose aspirin 55 Framingham Offspring Study 55 premenstrual syndrome PMS 55 hydroxyvitamin D levels 55 Health Initiative WHI 55 subclinical atherosclerosis 55 adrenal function 55 soy isoflavones 55 Netherlands Cohort Study 55 chronic prostatitis 54 polycystic ovarian syndrome 54 vulvovaginal atrophy 54 gestational diabetes mellitus 54 preterm delivery 54 osteoporotic fractures 54 subclinical hyperthyroidism 54 zoledronic acid 54 haemorrhagic stroke 54 colorectal adenoma 54 CARDIA study 54 folic acid supplement 54 amenorrhea 54 hot flushes 54 AVODART 54 adenoma 54 obese adolescents 54 nonvertebral fractures 54 hormone therapy HT 54 lasofoxifene 54 heavy menstrual bleeding 54 hypothyroid 54 folic acid intake 54 menstrual irregularities 54 gestational hypertension 54 femoral neck BMD 54 Health Initiative Observational 54 Prostate Lung Colorectal 54 vitamin E 54 PMDD 54 aromatase inhibitor therapy 54 Hormone supplements 54 climacteric symptoms 54 GnRH agonist 54 estrogen 54 Osteopenia 53 risedronate 53 serum IGF 53 urinary incontinence 53 intravenous bisphosphonates 53 ticlopidine 53 menarche 53 calcium supplements 53 colon polyp 53 dose oral contraceptives 53 undergone radical prostatectomy 53 timepoint 53 coronary calcification 53 Heavy menstrual bleeding 53 atypia 53 mammographic density 53 BRCA mutations 53 oral bisphosphonates 53 naturally occurring estrogen 53 menses 53 endometriosis ovarian cysts 53 adenomatous polyps 53 ovarian hormones 53 observational studies 53 calcium metabolism 53 mineral density 53 pregabalin 53 DHA supplementation 53 randomized controlled trials 53 aromatase inhibitor 53 LYSTEDA 53 placebo controlled clinical 53 valproate 53 advanced adenoma 53 knee OA 53 oral contraceptives 53 PREMPRO 53 BRCA mutation carriers 53 irregular menses 53 randomized clinical 53 pathologic fractures 53 hormonal contraception 53 nonmelanoma skin cancer 53 severe psoriasis 53 postmenopausal osteoporosis 53 selenium intake 53 preeclampsia 53 primary ovarian insufficiency 53 dysglycemia 53 folate deficiency 53 hypertensives 53 DEXA scan 53 metabolic syndrome 53 ibandronate 53 anastrozole 53 endometrial carcinoma 53 recurrent miscarriage 53 polyp recurrence 53 randomized trials 53 N telopeptide 53 undergone hysterectomies 53 Calcium intake 53 prophylactic mastectomy 53 screening mammography 53 NATRECOR R 53 virologic response 53 androgen deprivation 53 diabetes mellitus 53 glucose intolerance 53 Vitamin D supplements 53 breast tenderness 53 metabolic syndrome MetS 53 prepregnancy 53 serum uric acid 53 Postmenopausal Women 52 randomized clinical trials 52 index BMI 52 HNSCC 52 mg d 52 SHBG levels 52 dietary questionnaires 52 hypothalamic amenorrhea 52 liver transplant recipients 52 symptomatic fibroids 52 conjugated equine estrogens 52 alendronate Fosamax 52 menorrhagia 52 sedentary postmenopausal 52 hip fractures 52 endometrial cancers 52 Digital Mammographic Imaging 52 conjugated equine estrogen 52 androgen suppression 52 lobular breast cancer 52 Hypoactive Sexual Desire Disorder 52 NHANES III 52 lipid lowering medications 52 carotid atherosclerosis 52 serum testosterone 52 retrospective cohort 52 atypical hyperplasia 52 premenstrual symptoms 52 urinary tract symptoms LUTS 52 hyperemesis gravidarum 52 OAB symptoms 52 thiazide diuretics 52 elevated CRP 52 premenopause 52 endometriosis 52 adalimumab 52 polycystic ovary syndrome 52 venous thrombosis 52 atopic disease 52 nonmelanoma skin cancers 52 androgen therapy 52 microalbuminuria 52 cognitively normal 52 HIV seronegative 52 raloxifene Evista 52 basal cell nevus syndrome 52 iron deficient 52 prehypertensive 52 abnormal glucose tolerance 52 plasma folate 52 epithelial ovarian cancer 52 lignan intake 52 beta carotene supplementation 52 proliferative diabetic retinopathy 52 recurrent UTI 52 bisphosphonates 52 LNG IUS 52 DAPT 52 prepubertal 52 T2DM 52 cognitive function 52 serum phosphate 52 amenorrhoea 52 Perimenopause 52 ovulation induction 52 homocysteine levels 52 CLA supplementation 52 serum estradiol 52 prostate cancer PCa 52 Calcium supplementation 52 atrophic vaginitis 52 bacterial vaginosis 52 Oral contraceptives 52 carotid stenosis 52 severe menopausal symptoms 52 chlamydial infection 52 observational study 52 Osteoporotic Fractures 52 PROCRIT therapy 52 NATRECOR ® 52 vitamin D intake 52 flutamide 52 acrylamide intake 52 PSA screening 52 loop diuretics 52 lymph node removal 52 thrombophilia 52 hormone pills 52 selenium supplementation 52 menstrual periods 52 Invasive Breast Cancer 52 menstrual irregularity 52 postmenopausal estrogen 52 fragility fractures 52 neurodevelopmental outcome 52 Ovary removal 52 postmenopausal hormone 52 Hormone therapy 52 screening mammogram 52 phytoestrogen 52 inflammatory polyarthritis 52 dietary intakes 52 oestradiol 52 estradiol 52 atrophic gastritis 52 strontium ranelate 52 lifetime abstainers 52 elevated triglyceride levels 52 brain shrinkage 52 adjuvant therapy 52 uncomplicated pregnancies 51 vertebral fractures 51 atypical fractures 51 precocious puberty 51 nonvertebral fracture 51 statin 51 depressive symptoms 51 ischemic stroke 51 serum concentrations 51 abnormal mammograms 51 myocardial infarction 51 virologic failure 51 luteal phase 51 knee osteoarthritis OA 51 vaginal hysterectomy 51 tumor histology 51 cilostazol 51 thromboembolic disease 51 chemopreventive agent 51 alendronate 51 pattern baldness 51 BRCA testing 51 ovariectomy 51 serum selenium 51 leiomyomas 51 breastfed exclusively 51 Vitamin D supplementation 51 estrogen receptor positive 51 preterm deliveries 51 overt hypothyroidism 51 oral contraceptive pills 51 serum lipid levels 51 dietary supplementation 51 breast cancer recurrences 51 hereditary breast cancer 51 Oestrogen 51 benign proliferative breast 51 androgen deprivation therapy 51 singleton pregnancy 51 BMD measurements 51 surgically induced 51 thromboprophylaxis 51 β blockers 51 confidence interval #.#-#.# 51 narcolepsy cataplexy 51 euthyroid 51 Clinical Endocrinology & 51 recurrent venous thromboembolism 51 impaired glucose tolerance 51 luteal 51 ginkgo biloba extract 51 hydroxychloroquine 51 peri menopausal 51 calcium intakes 51 aneurysmal subarachnoid hemorrhage 51 baseline mammogram 51 RYGB surgery 51 Calcium vitamin D 51 hypoactive sexual desire 51 prospectively defined 51 serum testosterone levels 51 premenstrual dysphoric disorder PMDD 51 antihypertensive medications 51 BRCA2 mutation carriers 51 Venous thromboembolism 51 folic acid supplements 51 estrogen metabolites 51 HF ACTION 51 Swedish Mammography Cohort 51 benign breast 51 urinary oxalate 51 dietary calcium 51 hirsutism 51 colorectal cancer incidence 51 ACTOplus met XR 51 hypercholesterolaemia 51 #mg/day [001] 51 cerebral infarction 51 cervical lesions 51 randomized 51 impaired fasting glucose 51 dietary fat 51 improves insulin sensitivity 51 beta blocker therapy 51 ovulatory infertility 51 subfertility 51 endogenous estrogen 51 gestational diabetes 51 CVD mortality 51 coronary arteriography 51 hypocaloric diet 51 serum vitamin D 51 gallstone disease 51 beta carotene supplements 51 hypoglycemic episodes 51 BENICAR HCT 51 letrozole 51 HbA1c levels 51 stable angina 51 recurrent stroke 51 abnormal vaginal bleeding 51 statins 51 ovaries removed 51 reperfusion therapy 51 antiplatelet therapy 51 exemestane 51 randomized controlled trial 51 selenium supplements 51 NPH insulin 51 hypertension 51 corticosteroid therapy 51 colon polyps 51 serum cholesterol 51 BYSTOLIC 51 biochemical recurrence 51 Prostate Cancer Prevention 51 prolonged menstrual bleeding 51 vaginal estrogen 51 Young Adults CARDIA 51 BRCA2 mutation 51 hypercalcemia 50 irritable bowel syndrome IBS 50 metformin 50 serum GGT 50 cryptorchidism 50 premenstrual 50 Intrinsa 50 lamotrigine 50 LUTS 50 Premenopausal women 50 triglyceride levels 50 stress incontinence 50 breast carcinoma 50 homocysteine concentrations 50 ATACAND 50 EVISTA 50 myocardial infarction MI 50 elevated LDL cholesterol 50 systolic hypertension 50 nondepressed 50 Natural S equol 50 observational cohort study 50 cerebral microbleeds 50 hsCRP levels 50 APOE genotype 50 oral contraception 50 RLS symptoms 50 adequate calcium intake 50 BRCA carriers 50 adjuvant radiotherapy 50 osteoarthritis OA 50 cognitive decline 50 dietary intake 50 colorectal polyps 50 Communities ARIC study 50 HSDD 50 aspirin regimen 50 Hashimoto thyroiditis 50 underwent bariatric surgery 50 coronary heart 50 androgenetic alopecia 50 osteoporosis osteopenia 50 cardiovascular disease 50 systemic lupus erythematosus SLE 50 estrogen receptor ER 50 thyrotropin levels 50 APOE e4 50 endothelial dysfunction 50 EDARBI 50 antidiabetic medication 50 migraineurs 50 APTIVUS r 50 hypercholesterolemia 50 thromboembolism 50 transfusion syndrome 50 thrombolytic therapy 50 Ovarian PLCO Cancer 50 Estradiol 50 HPTN 50 pCR 50 bisphosphonate drugs 50 lipid lowering drugs 50 uterine fibroids 50 aspirin therapy 50 ViaDerm hPTH #-# 50 glycemic diet 50 advanced adenomas 50 postoperative AF 50 PMS symptoms 50 Polycystic Ovary Syndrome 50 retrospective cohort study 50 VADT 50 ALND 50 iron supplementation 50 proliferative retinopathy 50 milligram aspirin 50 cardioembolic stroke 50 dutasteride 50 Estrogens 50 antioxidant supplements 50 periodontal disease 50 ASCUS 50 randomized controlled clinical trials 50 Sarcopenia 50 vitamin D insufficiency 50 osteoarthritis 50 National Birth Cohort 50 urinary incontinence UI 50 myocardial ischemia 50 thromboembolic events 50 prescribed statins 50 androgenic alopecia 50 concomitant medications 50 treat menopausal symptoms 50 singleton pregnancies 50 multivariable adjusted 50 retrograde ejaculation 50 aromatase inhibitors AIs 50 endometrial thickness 50 fasting glucose 50 thrombotic events 50 screening colonoscopy 50 overactive bladder OAB 50 spine fractures 50 lobular involution 50 born preterm 50 arterial stiffening 50 limiting generalizability 50 estrogen pills 50 polycystic ovaries 50 mammary tumors 50 severe renal impairment 50 Pycnogenol 50 colorectal cancer 50 antioxidant supplementation 50 Zometa 50 menstrual cycles 50 Multicenter AIDS 50 urolithiasis 50 statin medications 50 adiponectin concentrations 50 adenoma recurrence 50 coronary artery calcification 50 prostate cancer CaP 50 colorectal neoplasia 50 overactive bladder symptoms 50 decreased libido 50 lumbar spine BMD 50 venous thromboembolism 50 hemoglobin A1c levels 50 HIV uninfected 50 PCa 50 synthetic progestin 50 breastfed infants 50 autoantibody positive 50 hydroxyvitamin D concentrations 50 substudy 50 NNRTI resistance 50 recurrent ovarian 50 postoperative mortality 50 atherogenic dyslipidemia 50 habitual snoring 50 uterine cancers 50 ARCOXIA 50 menstrual 50 thromboembolisms 50 hypertensive 50 IPAH 50 premenstrual dysphoric disorder 50 vitamin D 50 NSAID 50 androgen suppression therapy 50 Memory Study WHIMS 50 surgically menopausal 50 transferrin saturation 50 kidney transplant recipients 50 Estrogen therapy 50 undergoing hysterectomy 49 posaconazole 49 solifenacin 49 peri menopausal women 49 meta analysis 49 varicoceles 49 ductal breast cancer 49 LHRH agonists 49 late onset hypogonadism 49 NIDDM 49 warfarin therapy 49 HAART 49 bone resorption 49 estrogen progestin 49 Breast Cancer Risk 49 peginterferon 49 caffeine intake 49 placebo controlled trials 49 hyperandrogenism 49 tamsulosin 49 ApoE4 49 menstrual cycle 49 virological failure 49 postmenopausal osteoporotic women 49 poorer prognosis 49 Adjuvant chemotherapy 49 diabetes mellitus DM 49 invasive cervical cancer 49 DMARD 49 Normative Aging Study 49 abnormal Pap smears 49 multivitamin supplements 49 dysfunctional voiding 49 undergoing androgen deprivation 49 risedronate Actonel 49 serum calcium levels 49 thrombocytopenic 49 supplementation 49 Subgroup analyzes 49 oral antidiabetic medication 49 coronary revascularization 49 sarcopenia 49 Premenopausal 49 progestins 49 relieve menopausal symptoms 49 IBS C 49 vitamin D intakes 49 precancerous cervical 49 fasting insulin 49 ductal cancer 49 dyspareunia 49 antithrombotic therapy 49 operable breast cancer 49 desvenlafaxine succinate 49 vaginal progesterone gel 49 irregular ovulation 49 Ophena TM 49 density BMD 49 CI #.#-#.# [002] 49 macroalbuminuria 49 AVANDIA 49 HBeAg 49 serum parathyroid hormone 49 cervical carcinoma 49 Professionals Follow 49 cardiovascular disease CVD 49 SSRI antidepressants 49 fasting glucose levels 49 hyperintense lesions 49 alleviate menopausal symptoms 49 chorioamnionitis 49 lipoatrophy 49 pre eclampsia 49 ovarian cancer 49 telomere lengths 49 oral contraceptive pill 49 thyrotoxicosis 49 BRCA2 carriers 49 Vagifem 49 Tindamax R 49 IBS symptoms 49 iodine intake 49 pyridostigmine 49 nifedipine 49 lipid levels 49 flavonoid intake 49 nondrinkers 49 gonococcal infections 49 androgen excess 49 longitudinal study 49 paclitaxel eluting stents 49 HGPIN 49 diverticular bleeding 49 LDL cholesterol levels 49 bowel polyps 49 CMV infection 49 hysterectomy 49 isoflavones 49 C#BL/#J mice 49 autoimmune thyroid 49 elevated depressive symptoms 49 neural tube defect 49 hormonal contraceptives 49 unexplained infertility 49 fat diet 49 SE5 OH containing 49 body fatness 49 IDDM 49 estrogen progestin combination 49 placental malaria 49 gallbladder disease 49 macrovascular disease 49 premature menopause 49 QTc interval 49 undergoing bariatric surgery 49 periodontitis 49 folic acid supplementation 49 immunosuppressant therapy 49 LHRH agonist 49 distant metastases 49 pelvic lymphadenectomy 49 enlarged prostates 49 virological response 49 dysmenorrhoea 49 MGUS 49 adjuvant chemotherapy 49 ICDs implanted 49 nulliparous 49 glucose intolerant 49 proteinuria 49 bone metastasis 49 familial adenomatous polyposis 49 ximelagatran 49 mg dose 49 MMSE scores 49 Screening Trial 49 APOE ε4 49 Calcium supplements 49 BRCA1 mutation carriers 49 black cohosh 49 corticosteroid induced 49 axillary dissection 49 oral antidiabetic drugs 49 postpartum hemorrhage 49 albumin excretion 49 randomized controlled clinical 49 recurrent acute pancreatitis 49 epithelial ovarian 49 prospective multicentre 49 GBA mutations 49 Baltimore Longitudinal Study 49 genistein 49 mycophenolate mofetil 49 macrovascular 49 androgen ablation 49 estradiol gel indicated 49 plus medroxyprogesterone acetate 49 urothelial cancer 49 painful menstrual periods 49 oral bisphosphonate 49 ARICEPT 49 Fatty Liver Disease 49 spine BMD 49 magnesium supplementation 49 lichen planus 49 ovulate 49 lobular cancer 49 periprocedural MI 49 bazedoxifene 49 candesartan 49 cardiorespiratory fitness 49 urate levels 49 HBeAg negative 49 canakinumab 49 liver biopsies 49 colon tumors 49 preoperative chemotherapy 49 prolonged QT interval 49 subtrochanteric 49 arterial thickening 49 Zoledronic acid 49 endometrial 49 glycemia 49 hormones estrogen 49 neurodevelopmental outcomes 49 dyslipidaemia 49 metreleptin 49 pravastatin therapy 49 venous thromboembolic disease 49 vitamin D supplements 49 invasive carcinoma 49 Subgroup analysis 49 recurrent miscarriages 49 eptifibatide 49 Hydroxyurea 49 serum folate concentrations 49 CHD mortality 49 vitamin D supplement 49 neurocognitive function 49 plus progestin 49 homozygous familial hypercholesterolemia 49 Viread Emtriva 49 insulin detemir 49 salpingo oophorectomy 49 pre eclamptic 49 RCTs 49 odanacatib 49 thromboembolic 49 Zoledronic Acid 49 Leitzmann 49 TT genotype 49 Hilakivi Clarke 49 fasting triglyceride levels 49 oral ibandronate 49 preterm birth 49 WHI 49 abnormal cytology 49 adjuvant hormonal therapy 49 abnormal uterine bleeding 49 NAFLD 49 BRCA gene mutation 49 Wisconsin Sleep Cohort 49 intestinal polyps 49 preventive mastectomies 49 lowfat diet 49 BRCA gene mutations 49 hyperglycaemia 49 TZDs 49 plasma selenium 49 serum ferritin 49 CAVEATS 49 CrCl 49 steroid dexamethasone 49 PREZISTA r 49 GERD symptoms 49 sudden sensorineural hearing 49 choline intake 49 Postmenopausal women 49 rosuvastatin 49 CaP 49 glitazones 49 atopic 49 hypogonadotropic hypogonadism 49 systolic BP 49 dopaminergic therapy 49 CYP#D# inhibitor 49 glucosamine supplements 49 dietary patterns 49 postoperative atrial fibrillation 49 TEAEs 49 pelvic pain 49 pioglitazone 49 variceal bleeding 49 carotid intima media 49 prostate cancer CRPC 49 systemic corticosteroid 49 elevated triglycerides 49 DHA supplements 49 menopausal hormone 49 eribulin 49 prediabetic 49 incontinence episodes 49 plasma homocysteine levels 48 endometrial biopsy 48 Prempro pills 48 recurrent metastatic 48 NAT2 48 % CI #.#-#.# [003] 48 non fasting triglycerides 48 ARIXTRA 48 parous 48 HIV HCV coinfected 48 episodic migraine 48 obstetric complications 48 menstrual pain 48 multicenter 48 potassium sparing diuretics 48 HCV infected 48 induce ovulation 48 Faslodex 48 CMV disease 48 HeFT 48 pancreatic adenocarcinoma 48 methotrexate therapy 48 HRQOL 48 Atherosclerosis MESA 48 underwent prostatectomy 48 gestational diabetes mellitus GDM 48 renal function 48 Prostatitis 48 alpha blocker 48 aminotransferases 48 depot medroxyprogesterone acetate 48 epidemiological studies 48 hormonal therapies 48 drank caffeinated 48 HBeAg positive 48 onset puberty 48 menopause symptoms 48 nonmetastatic prostate cancer 48 localized prostate cancer 48 Adequate vitamin D 48 onset diabetes mellitus 48 Severe Primary IGFD 48 gonadotropins 48 multivessel disease 48 biochemical relapse 48 folate 48 dapagliflozin plus 48 multicenter study 48 symptomatic BPH 48 abdominal adiposity 48 mild cognitive impairment 48 antidepressant therapy 48 Alendronate 48 efalizumab 48 non aspirin NSAIDs 48 nonfatal MI 48 artery calcification 48 alcoholic fatty liver 48 iPrEx study 48 mixed hyperlipidemia 48 oropharyngeal cancer 48 oral antidiabetic agents 48 VaD 48 STRIDE PD 48 autonomic dysfunction 48 nocturia 48 recurrent UTIs 48 EBRT 48 renal flares 48 breast endometrial 48 juvenile idiopathic arthritis 48 #mg/day [002] 48 VCUG 48 nephrolithiasis 48 phytoestrogen intake 48 nonobese 48 insulin glargine 48 tolvaptan 48 calcium vitamin D 48 Kivipelto 48 hormone receptor positive 48 colorectal neoplasms 48 subclinical 48 HER2 expression 48 atopy 48 morphometric vertebral fractures 48 THIS STUDY 48 candesartan cilexetil 48 dietary antioxidants 48 chemoradiotherapy 48 ischemic strokes 48 RSD# oral 48 Screening Trial DMIST 48 venous blood clots 48 pathologic fracture 48 LQTS 48 folic acid 48 asymptomatic 48 follicular phase 48 epidemiologic studies 48 Multi Ethnic Study 48 hemorrhagic strokes 48 NSAIDs 48 clomiphene citrate 48 #.#g/day 48 DHEA supplementation 48 BRCA2 gene mutation 48 recurrent preterm birth 48 lymph node dissection 48 transaminase levels 48 Stop Hypertension diet 48 nondemented 48 coronary disease 48 paroxysmal AF 48 cTnT 48 yearly mammograms 48 ventricular tachyarrhythmia 48 Multiethnic Study 48 isoflavone supplements 48 carbohydrate intolerance

Back to home page